Clinical Trials Directory

Trials / Completed

CompletedNCT00121394

Chlorhexidine Vaginal and Infant Wash in Pakistan

Randomized Trial of Chlorhexidine Vaginal and Infant Wash to Reduce Neonatal Mortality

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
5,008 (actual)
Sponsor
NICHD Global Network for Women's and Children's Health · Network
Sex
Female
Age
16 Years
Healthy volunteers
Accepted

Summary

Infection is a major health problem during birth in Pakistan. This study will look at the possibility of using a septic wash to help improve health during birth in Karachi, Pakistan.

Detailed description

Sepsis in mother and infant is a major cause of perinatal morbidity and mortality in low-resource settings. Several studies have investigated the likelihood that an anti-bacterial agent, chlorhexidine, administered during labor and delivery to mother and infant could reduce the risk of infection and of subsequent maternal and infant morbidity and mortality. In this trial, chlorhexidine wash and placebo will be randomly administered to women in labor and newborn infants in a public hospital in Karachi, Pakistan. Delivery attendants will administer 0.6% chlorhexidine solution every four hours until delivery (4 washes maximum) and one neonatal wash with the same solution. The control group will receive 200 ml of sterile physiologic saline solution. A total of 5000 women will be randomized in the hospital study, 2500 control and 2500 intervention. All women and infants will be evaluated 24 hours post delivery and at a 7-day follow-up. Women who delivered at home will also receive a 28 days post-partum assessment. Women will be carefully monitored for side effects to the dosage. In addition a community-based feasibility trial of 200 patients (100 CHX, 100 control) will be completed.

Conditions

Interventions

TypeNameDescription
PROCEDUREChlorhexidine vaginal and infant wash

Timeline

Start date
2005-06-01
Primary completion
2008-06-01
Completion
2008-06-01
First posted
2005-07-21
Last updated
2014-07-31

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT00121394. Inclusion in this directory is not an endorsement.